189 related articles for article (PubMed ID: 23062158)
21. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
22. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
Villar E; Lièvre M; Kessler M; Lemaître V; Alamartine E; Rodier M; François M; Zaoui P; Moranne O; Choukroun G; Guerraoui A; Jolivot A; Janin G; Branger B; Heng AE; Boudray C; Bissery A; Rabilloud M; Pouteil-Noble C
J Diabetes Complications; 2011; 25(4):237-43. PubMed ID: 21601481
[TBL] [Abstract][Full Text] [Related]
23. Screening and management of patients with early chronic kidney disease.
Rossert J; Fouqueray B
Acta Diabetol; 2004 Mar; 41 Suppl 1():S6-12. PubMed ID: 15103542
[TBL] [Abstract][Full Text] [Related]
24. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
25. Chronic kidney disease: prevention and treatment of common complications.
Snively CS; Gutierrez C
Am Fam Physician; 2004 Nov; 70(10):1921-8. PubMed ID: 15571058
[TBL] [Abstract][Full Text] [Related]
26. Clinical practice. Stage IV chronic kidney disease.
Abboud H; Henrich WL
N Engl J Med; 2010 Jan; 362(1):56-65. PubMed ID: 20054047
[No Abstract] [Full Text] [Related]
27. Detection and evaluation of chronic kidney disease.
Snyder S; Pendergraph B
Am Fam Physician; 2005 Nov; 72(9):1723-32. PubMed ID: 16300034
[TBL] [Abstract][Full Text] [Related]
28. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
Lam A; Shah S; Paparello J
Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654
[TBL] [Abstract][Full Text] [Related]
29. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
30. Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.
Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2010 Apr; 11(5):723-30. PubMed ID: 20210681
[TBL] [Abstract][Full Text] [Related]
31. [Chronic kidney disease: therapy and care].
Noel N; Gaha K; Rieu P
Rev Prat; 2012 Jan; 62(1):43-51. PubMed ID: 22335066
[TBL] [Abstract][Full Text] [Related]
32. Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
Drüeke TB; Locatelli F; Clyne N; Eckardt KU; Macdougall IC; Tsakiris D; Burger HU; Scherhag A;
N Engl J Med; 2006 Nov; 355(20):2071-84. PubMed ID: 17108342
[TBL] [Abstract][Full Text] [Related]
33. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
[TBL] [Abstract][Full Text] [Related]
34. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
35. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
36. [Guidelines for diagnosis and therapy of diabetic nephropathy].
De Ferrari G;
G Ital Nefrol; 2003; 20 Suppl 24():S96-108. PubMed ID: 14666506
[TBL] [Abstract][Full Text] [Related]
37. [Definition, diagnosis, grading and treatment of chronic kidney disease (CKD): an update].
Kamata K
Masui; 2013 Nov; 62(11):1284-92. PubMed ID: 24364269
[TBL] [Abstract][Full Text] [Related]
38. Risk of stroke in kidney disease.
Ninomiya T
Contrib Nephrol; 2013; 179():58-66. PubMed ID: 23652449
[TBL] [Abstract][Full Text] [Related]
39. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.
National Kidney Foundation
Am J Kidney Dis; 2012 Nov; 60(5):850-86. PubMed ID: 23067652
[TBL] [Abstract][Full Text] [Related]
40. Workup for proteinuria.
Snyder S; John JS
Prim Care; 2014 Dec; 41(4):719-35. PubMed ID: 25439530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
